101 related articles for article (PubMed ID: 3246784)
21. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
[TBL] [Abstract][Full Text] [Related]
22. [Tumor marker squamous cell carcinoma antigen].
Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
[No Abstract] [Full Text] [Related]
23. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistochemical study of a flat epithelial antigen and prospects for using it as a marker for squamous cell carcinoma].
Ievleva ES; Shcherbitskaia IIa; Samratova SS; Marshutina NVa IIa; Pugachev KK
Biull Eksp Biol Med; 1995 Feb; 119(2):209-11. PubMed ID: 7670057
[No Abstract] [Full Text] [Related]
25. [Availability of the carbohydrate antigen (sialylated Lewis) as a tumor marker in pleural effusion].
Hiratani K; Hirota M; Fukushima K; Tomonaga A; Saito A; Hara K; Fujiwara K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2678-80. PubMed ID: 3017233
[No Abstract] [Full Text] [Related]
26. [Tumor markers for lung neoplasm].
Sekido Y
Nihon Rinsho; 2002 May; 60 Suppl 5():229-32. PubMed ID: 12101663
[No Abstract] [Full Text] [Related]
27. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma antigen.
Kerawala C
Oral Oncol; 2006 Jan; 42(1):3-4. PubMed ID: 16140567
[No Abstract] [Full Text] [Related]
29. Squamous cell carcinoma antigen as a biomarker for penile cancer.
Kommu S; Hadway P; Watkin N
BJU Int; 2005 Mar; 95(4):478-9. PubMed ID: 15705062
[No Abstract] [Full Text] [Related]
30. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic value of carcinoembryonic antigen in pleural effusion and peripheral serum from patients with pleuritis].
Kinoshita M; Wagai F; Watanabe H; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Mar; 22(3):197-201. PubMed ID: 6748400
[No Abstract] [Full Text] [Related]
33. [Serum squamous cell carcinoma-related antigen in lung cancer--a marker for the extent of the disease and response to therapy].
Reshad K; Inui K; Takahashi Y; Itoi K; Nakano Y; Sakamoto M; Suzuki K
Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Aug; 24(8):878-83. PubMed ID: 3795641
[No Abstract] [Full Text] [Related]
34. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Cyfra 21-1 as a marker for lung cancer.
Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
[TBL] [Abstract][Full Text] [Related]
36. [Cytology of pleural effusion].
Leonhardt P
Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):367-78. PubMed ID: 5210836
[No Abstract] [Full Text] [Related]
37. [A clinical study on CEA, TPA, ADA, ferritin, beta 2 microglobulin and sialic acid levels in pleural effusion].
Reshad K; Suzuki K; Itoi K; Takahashi Y; Hirata T; Yagi T; Sato A; Nakano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1174-80. PubMed ID: 3329690
[No Abstract] [Full Text] [Related]
38. New approaches in the diagnostic procedure of malignant pleural effusions.
Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
[TBL] [Abstract][Full Text] [Related]
39. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients.
Aoe K; Hiraki A; Yamazaki K; Nakamura Y; Murakami T; Maeda T; Nishimura M; Sugi K; Ueoka H
Int J Oncol; 2006 Jul; 29(1):65-72. PubMed ID: 16773186
[TBL] [Abstract][Full Text] [Related]
40. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
